European Journal of Epidemiology

Papers
(The H4-Index of European Journal of Epidemiology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Associations of coagulation parameters and thrombin generation potential with the incidence of type 2 diabetes: mediating role of glycoprotein acetylation665
Influence of consuming coffee and other beverages in adolescence on risk of type 2 diabetes in adulthood311
Economic uncertainty and suicide in the United States254
Age-specific effects of weight-based body size on fracture risk in later life: a lifecourse Mendelian randomisation study133
Occupational solar exposure and basal cell carcinoma. A review of the epidemiologic literature with meta-analysis focusing on particular methodological aspects127
The impact of a healthy lifestyle on the risk of esophageal and gastric cancer subtypes88
The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review86
The association of myocardial infarction with cancer incidence77
Losing the Public, for Better or for Worse: A Lesson from John Everett Gordon (1890–1983) and John Rodman Paul (1893–1971)69
A population-based cohort of drug exposures and adverse pregnancy outcomes in China (DEEP): rationale, design, and baseline characteristics67
Authors’ reply to Grundtvig Gram et al.66
The relationship between air pollution and multimorbidity: Can two birds be killed with the same stone?61
Authors’ Reply: Interpreting epidemiologic studies of colorectal cancer prevention59
Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula58
Prevalence and incidence of mastocytosis in adults: a Danish nationwide register study58
Over- and under-estimation of COVID-19 deaths55
Continued decline in the incidence of myocardial infarction beyond the COVID-19 pandemic: a nationwide study of the Swedish population aged 60 and older during 2015–202252
Association between serum pyrethroid insecticide levels and incident type 2 diabetes risk: a nested case–control study in Dongfeng–Tongji cohort45
The Swedish medical birth register during five decades: documentation of the content and quality of the register45
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study43
Partial substitution of red meat or processed meat with plant-based foods and the risk of colorectal cancer43
The baseline examinations of the German National Cohort (NAKO): recruitment protocol, response, and weighting42
Incidence and prevalence of Alzheimer’s disease in China: a systematic review and meta-analysis42
Cognitive ability, education, height and body mass index in relation to risk of schizophrenia and mortality following its diagnosis40
Increasing transparency of decision making in research practice: adding value or just more red tape?40
Re: Interpreting epidemiologic studies of colonoscopy screening for colorectal cancer prevention39
Towards more reliable non-linear mendelian randomization investigations38
The diverse life-course cohort (DLCC): protocol of a large-scale prospective study in China37
Breast cancer risk in Ukrainian women exposed to Chornobyl fallout while pregnant or lactating: standardized incidence ratio analysis, 1998 to 201635
Causes of death in individuals exposed to spousal, parental, and child suicide: a nationwide population-based cohort comparison study33
Improving the reporting of non-inferiority trials by incorporating non-efficacy benefits: not all non-inferiority trials are created equal33
The need for evolutionary theory in cancer research32
Metabolic profiling of smoking, associations with type 2 diabetes and interaction with genetic susceptibility32
Cohort profile: the China surgery and anesthesia cohort (CSAC)32
The perpetual need of randomized clinical trials: challenges and uncertainties in emulating the REDUCE-AMI trial32
0.079823017120361